3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Cardiotoxicity
14
Breast Neoplasms
10
Neoplasms
4
Heart Failure
4
Heart Diseases
2
Cardiovascular Diseases
2
Ventricular Dysfunction, Left
1
Ventricular Dysfunction
1
Thoracic Neoplasms
1
Radiation Injuries
1
Prostatic Neoplasms
1
Peritoneal Neoplasms
1
Myeloproliferative Disorders
1
Multiple Myeloma
1
Metabolic Syndrome
1
Memory Disorders
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Follicular
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hereditary Breast and Ovarian Cancer Syndrome
1
Dyspnea
1
Dyslipidemias
1
Cognitive Dysfunction
1
Central Nervous System Neoplasms
1
Cardiomyopathies
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms, Male
1
Bone Neoplasms
1
Atherosclerosis
1
Interventions
Carboplatin
7
atezolizumab
3
Paclitaxel
3
apatinib
2
Pemetrexed
2
Erlotinib Hydrochloride
2
Bevacizumab
2
toripalimab
1
sintilimab
1
pegylated granulocyte colony-stimulating factor
1
durvalumab
1
cemiplimab
1
camrelizumab
1
Vinorelbine
1
Ultrasonography
1
Tyrosine Kinase Inhibitors
1
Telescopes
1
Sunitinib
1
Sodium Chloride
1
Radiotherapy
1
Radiosurgery
1
Proton Therapy
1
Nivolumab
1
Metformin
1
Magnetic Resonance Imaging
1
Kyphoplasty
1
Intubation
1
Injections, Epidural
1
Injections
1
Indocyanine Green
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Thoracic Neoplasms
×
Echocardiography
×
Clear all
NCT03396614
2024-02-28
CROSS SECT
University Medical Center Groningen
Completed
40 enrolled